Marijuana and Psychosis – Possible Link

 

Pot Use in Youth Ups Risk of Psychotic Symptoms in Later Life

The new findings are based on data on about 2,000 individuals in Germany who were 14 to 24 years old when they enrolled in the study, and who were then followed for 10 years. 

None of the participants had ever tried marijuana before entering the study, nor had any experienced psychotic symptoms.

The researchers found that those who started smoking pot during the 10 years of the trial had double the risk of developing psychotic symptoms such as hallucinations, even after adjusting for factors such as age, sex, socioeconomic status, other drug use and other psychiatric diagnoses.

And the more persistent the use, the more persistent the symptoms.

Chandler police link beheading to theft of marijuana from Mexican cartel – East Valley Tribune: Cop Shop

Azilsartan Medoxomil (Edarbi)

Medical News: New ARB Cleared for Hypertension Treatment – in Cardiovascular, Hypertension from MedPage Today

The FDA has approved azilsartan medoxomil (Edarbi), an oral angiotensin II receptor blocker (ARB) for hypertension, expanding the ranks of ARBs now available to U.S. patients.

TAK-491 would have been a better brand name IMHO.

Australian Opportunity

Australian Life Underwriters: Our client is seeking experience Life Insurance Underwriters. 457 Visa Sponsorship may be offered to right candidate. Konnecting – Skilled Migration & Recruitment
Started by Fred Molloy, Australian Registered Migration Agent
contact recruit@konnecting.com
By Fred Molloy, Australian Registered Migration Agent

 

I haven’t clicked on the links but I think they work.  This opening was sent to me via email.

Breast Implants and Anaplastic Large Cell Lymphoma (ALCL)

Safety Alerts for Human Medical Products > Breast Implants: FDA Review Indicates Possible Association With A Rare Cancer

FDA announced a possible association between saline and silicone gel-filled breast implants and anaplastic large cell lymphoma (ALCL), a very rare type of cancer. Data reviewed by the FDA suggest that patients with breast implants may have a very small but significant risk of ALCL in the scar capsule adjacent to the implant.